Cite
Health-related quality of life effect of mogamulizumab by patient blood involvement
MLA
Pablo L. Ortiz-Romero, et al. Health-Related Quality of Life Effect of Mogamulizumab by Patient Blood Involvement. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d545987db914e7af62c8bce16d3fe0ef&authtype=sso&custid=ns315887.
APA
Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Margarida Lima, & Auris Huen. (2021). Health-related quality of life effect of mogamulizumab by patient blood involvement.
Chicago
Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Margarida Lima, and Auris Huen. 2021. “Health-Related Quality of Life Effect of Mogamulizumab by Patient Blood Involvement,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d545987db914e7af62c8bce16d3fe0ef&authtype=sso&custid=ns315887.